Aimei Health Technology Co., Ltd (AFJK)

Aimei Health Technology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023
Cash & Equivalents	0	0.03	0.58
Cash & Short-Term Investments	0	0.03	0.58
Cash Growth	-97.12%	-95.14%	-
Prepaid Expenses	0.02	0	-
Total Current Assets	0.02	0.03	0.58
Other Long-Term Assets	45.44	73.78	69.89
Total Assets	45.47	73.81	70.47
Accrued Expenses	0.29	0.3	0.02
Short-Term Debt	1.66	0.23	-
Other Current Liabilities	0.83	0.29	-
Total Current Liabilities	2.77	0.82	0.02
Other Long-Term Liabilities	46.13	74.47	70.58
Total Liabilities	48.91	75.29	70.6
Common Stock	0	0	0
Retained Earnings	-3.44	-1.48	-0.13
Shareholders' Equity	-3.44	-1.48	-0.13
Total Liabilities & Equity	45.47	73.81	70.47
Total Debt	1.66	0.23	-
Net Cash (Debt)	-1.65	-0.2	0.58
Net Cash Per Share	-0.23	-0.02	0.26
Filing Date Shares Outstanding	6.12	8.03	9.03
Total Common Shares Outstanding	6.12	9.03	9.03
Working Capital	-2.75	-0.79	0.56
Book Value Per Share	-0.56	-0.16	-0.01
Tangible Book Value	-3.44	-1.48	-0.13
Tangible Book Value Per Share	-0.56	-0.16	-0.01

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q